Tatar, B. Et Al. 2019. Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: A clinical experience. Revista da Associacao Medica Brasileira , vol.65, no.12 , 1470-1475.

Tatar, B., KÖSE, Ş., Ergun, N. C., Turken, M., ÖNLEN, Y., YILMAZ, Y., ... AKHAN, S.(2019). Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: A clinical experience. Revista da Associacao Medica Brasileira , vol.65, no.12, 1470-1475.

Tatar, Bengu Et Al. "Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: A clinical experience," Revista da Associacao Medica Brasileira , vol.65, no.12, 1470-1475, 2019

Tatar, Bengu Et Al. "Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: A clinical experience." Revista da Associacao Medica Brasileira , vol.65, no.12, pp.1470-1475, 2019

Tatar, B. Et Al. (2019) . "Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: A clinical experience." Revista da Associacao Medica Brasileira , vol.65, no.12, pp.1470-1475.

@article{article, author={Bengu Tatar Et Al. }, title={Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: A clinical experience}, journal={Revista da Associacao Medica Brasileira}, year=2019, pages={1470-1475} }